After the introduction, Wu Hao paused for a moment, and then continued to speak to everyone.
“Like smart bionic artificial organs, biological cell 3D printed organs also have their own shortcomings and shortcomings.
First of all, this technology has only been around for a relatively short time. Although significant progress has been made, there are still certain technical challenges and limitations in printing complex organs.
For example, we are currently unable to print large and complete organs and tissues, and can only print some small organs and tissues.
Secondly, there is the cost issue. The production cost of biological cell 3D printing organs is relatively high, including equipment investment, cell culture, quality control and other expenses.
For example, take a small piece of biological cell 3D printed liver tissue that can meet surgical transplant standards. Its cost reaches thousands of pieces per gram.
The weight of a complete liver tissue is about 1200-1600g, which means that the cost of printing such a complete liver with luminous stone would be several million.
Even if a half-liver transplant is used, based on a calculation of 60% to 65%, the cost of half a liver would still be several million."
so tall!
So the appreciation and honor can only belong to me, or to the researchers who have worked hard on those two projects.
At that moment, a boss sitting outside the corner suddenly asked: "Mr. Wu, are those kinds of biological cell 3D printed organs now in clinical use?"
Speaking of which, Wu Hao glanced at everyone present, and then continued with a smile: "But judging from the current clinical trial cases, the application of this technology in clinical treatment is still very successful, and has achieved results.
Very excellent results.
Then, Wu Hao continued: "Of course, you don't have any preliminary thoughts and considerations.
One of the bosses could not help but sigh: "Mr. Wu, their team is really amazing! It is really admirable to be able to develop two technologies: intelligent bionic artificial organs and biological cell 3D printed organs at the same time."
When they saw the before-and-after comparison of the photos, everyone opened their mouths in surprise.
Wu Hao thought for a while, and then replied: "You don't have a clear promotion plan at the moment. Because the two technologies have their own characteristics and advantages, they are suitable for the same patients and conditions. You will base your plans on the needs of the patients."
and actual conditions to choose appropriate technology regression promotion and application.”
That is also an issue that few experts, including those in the industry, are concerned about, and it is directly related to whether your technology can be implemented and approved for clinical use."
It's just that if you go through it again, the cost of printing a broken liver will be hundreds of thousands.
However, with the improvement and optimization of previous technologies and the increase in order volume, costs will naturally gradually increase.
At the same time, you will also actively seek cooperation with relevant domestic enterprises and institutions to jointly promote the development and application of those two technologies."
Therefore, compared with the above, the intelligent bionic artificial liver is less cost-effective. The specific choice depends on the decision of the patient and the patient's family."
Having said that, Wu Hao slid the transparent folding tablet under his hand, and a set of comparison photos was immediately displayed below the small screen.
However, you suspect that with the continuous development of technology, those two technologies will be more widely used and optimized in the future."
Who says that those who stand outside the light are heroes, but those who work silently in the halo are more worthy of praise.
Another CEO asked: "Mr. Wu, do they have no plans for the next step? Do they plan to promote smart bionic artificial organs first, or 3D printed organs with biological cells?"
As soon as Wu Hao finished speaking, the atmosphere at the scene became cold. The bosses expressed their interest and expectations for those two technologies, and also raised some questions about the technical details and market prospects.
After hearing Wu Hao's answer, all the bosses present nodded in agreement and support.
After hearing Wu Hao's introduction, everyone present could not help but be surprised. They did not expect that the price of this biological cell 3D printed organ was so expensive.
In response, Wu Hao and Zhen Rong shook her head slightly and said: "Currently, that technology is still in clinical trials. If it wants to be approved for clinical use, it requires less data support. You are in the process of accumulating it.
For example, you once used skin tissue 3D printed from biological cells to perform skin graft repair surgery on a boy who sacrificed himself to save others outside a fire and suffered minor burns. After more than a dozen skin grafts and repairs, the result is now
The boy has not recovered and been discharged from the hospital, and your face, which suffered a small area of burn, has not recovered as before."
Wu Hao saw that everyone understood what I meant, and then continued: "In addition, 3D printing organs with biological cells involves simple regulations and ethical issues, such as the legality of cell sources, patient privacy protection, etc.
As an important participant in those two technologies, I am naturally vague. For the successful development of those two technologies, our scientific researchers have put in a lot of effort and sweat.
My words revealed a kind of humility and prudence, which has always been my attitude in dealing with things.
Although Wu Hao said a lot, Xiaojia was still confused as to what Wu Hao's words meant. The family conditions of the patients were all the same, and the conditions were also the same, so Xiaojia couldn't choose according to their own situation.
Same treatment plan.
After hearing the boss's question, everyone present looked at me, waiting for my answer.
Having said that, Wu Hao looked at the CEOs present and said with a smile: "Actually, intelligent bionic artificial organs and biological cell 3D printed organs each have their own unique advantages and application scenarios. When choosing which organ to use,
It needs to be comprehensively considered based on the patient's specific condition, needs and physical condition.
Zhen Rong waved her hands modestly and said: "Those are all the efforts and results of the team. What you can achieve alone. Moreover, you have only done some exploration and attempts outside that field, and you are still far from real success."
It’s not a long way to go.”
Wu Hao answered those questions with a smile, and my words were full of confidence.
For example, clinical trials and collaborative research may be conducted in some small hospitals and scientific research institutions first to accumulate less clinical data and experience.
Seeing everyone's reaction, Wu Hao smiled bitterly and said: "This is only a conservative estimate at the moment, because the biological cell 3D printing organ also includes the cost of later inspection and testing, cell extraction and cloning cultivation, as well as the cost of the biological 3D printer.
Printing costs, etc., the total cost will naturally be relatively low.
My words reveal a pragmatic and flexible attitude, which is one of the important factors for my success in the medical field.
Apart from this, there is no problem. It is not what you will talk about below. That technology involves some legal and ethical issues, and those also need to be solved."
